About The ASCR Network
The Adult Stem Cell Research (ASCR) Network is an Internet-based project of The Cell Therapy Foundation designed to be a well-maintained and reliable source of information for the public regarding adult stem cell research, as well as to be a community of practice and collaboration among fellow researchers. ASCR publishes the latest scientific news in the adult stem cell arena, identifies the leading researchers in the field, and locates key clinical trials; as well as connects the global community of adult stem cell researchers with one another.
IntelliCell BioSciences Receives US Patent for its Stem Cell Extraction Technology
NEW YORK, June 13, 2013 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (SVFC) announces that it has been notified by the US Patent office that its patent for stem cell extraction technology has been published. IntelliCell's proprietary patented method for deriving blood vessel originated vascular cells from adipose (fat) tissue by use of ultrasonic cavitation has been made official. This technology involves an innovative mechanical method for the separation of stromal vascular fraction cells from adipose (fat) tissue, without the use of enzymes. Vascular cells derived by IntelliCell's proprietary method are potentially useful in bringing the promise of regenerative medicine to many therapeutic and aesthetic procedures. Investors can access the published patent at the US Patent website by entering the patent # 8,440,440. Link to patent website: http://patft.uspto.gov/netahtml/PTO/srchnum.htm
Apceth Wins Approval for Trial with Engineered Adult Stem Cell Cancer Therapy
Cell therapies firm apceth has won regulatory clearance in Germany to start an open-label mulitcentre Phase I/II trial evaluating its genetically modified, autologous adult mesenchymal stem cell (MSC) therapy, Agenmestencel-T, in adult patients with advanced adenocarcinoma of the gastrointestinal tract.
Agenmestencel-T is generated from the patient’s own MSCs. The cells are harvested from the bone marrow, engineered to carry a cancer-targeting cytotoxic gene product based on a based on gamma-SIN-vector, and then readministered into the patient. Therapy is designed to be activated only at the tumor site, to increase local efficacy and reduce systemic toxicity.
Bioheart Announces Phase I ANGEL Trial Completed
SUNRISE, FL--(Marketwired - Jun 12, 2013) - Bioheart, Inc. (OTCQB: BHRT) announced today that they have successfully enrolled and treated all patients in the phase I ANGEL Trial. The trial, which is fully funded by Bioheart, is being conducted in Mexico at the Hospital Angeles with the Regenerative Medicine Institute (RMI). This phase I study will provide necessary safety and preliminary efficacy of adipose-derived stem cells in patients with congestive heart failure. Endpoints include safety, exercise capacity, quality of life, and ejection fraction at 3 months, 6 months and 12 months.
Kristin Comella, Bioheart's Chief Science Officer, said, "We were so excited to see brisk enrollment in the study. Once we collect preliminary safety and efficacy, we will expand the study into a Phase II trial."
Global expert in lung disease joins Cedars-Sinai to lead new stem cell research program
Researcher brings with him $5M CIRM leadership award grant
LOS ANGELES – (June 11, 2013) – Barry R. Stripp, PhD, a recognized expert in lung disease and stem cell research, has been named director of the new Lung Stem Cell Research Program that spans the Women’s Guild Lung Institute and the Regenerative Medicine Institute at Cedars-Sinai.
Stripp comes to Cedars-Sinai from Duke University Medical Center in Durham, N.C., where he has been professor in both the Department of Medicine and in Cell Biology since 2006. At Duke University Medical Center, Stripp was a member of the Division of Pulmonary, Allergy and Critical Care Medicine, led by Paul W. Noble, MD, who is now chair of the Department of Medicine at Cedars-Sinai. The recruitment of Stripp and Noble to Cedars-Sinai brings two leaders in lung disease research whose highly interactive programs have potential to develop new treatments.
* Designates sites with available clinical trials.
- * Adult Stem Cell Laboratory, Medical College of Georgia
- * Feinberg Cardiovascular Research Institute - Northwestern University, Chicago, IL
- * Indiana Center for Vascular Biology and Medicine, Laboratories - Indianapolis, IN
- * Regenerative Medicine Institute, Mexico
- * Stem Cell Center at Texas Heart Institute - Houston, TX
- Adipose Stem Cell Center, University of Pittsburgh - Pittsburgh, PA
- Adipose Tissue Plasticity - Toulouse France
- Adult Stem Cell Laboratory - Seoul, South Korea
- Adult Stem Cell Research Ctr, Seoul National University - Seoul, South Korea
- The Cardiovascular Research Institute - Washington, DC
- Center for Cardiovascular Cell Therapy - Louisville, KY
- Division of Clinical Immunology and Transfusional Medicine - Stockholm, Sweden
- Excellion Biomedical Services - Petropolis, Rio de Janeiro
- Interdisciplinary Stem Cell Institute/UM Med - Miami, FL
- Institute of Cell and Molecular Science - London, England
- Kolonin Lab - Centre for Stem Cell Research - Houston, TX
- Laboratory for Stem Cell Injury - Charleston, SC
- LIT - Laboratory of Transplantation Immunobiology - Sao Paulo, Brazil
- Minneapolis Heart Institute Foundation - Minneapolis, MN
- Molecular Cardiology Laboratory - ThoraxCenter - Rotterdam, Netherlands
- National Centre for Adult Stem Cell Research at Griffith University - Nathan Queensland, Australia
- Naviaux Lab - The Mitochondrial and Metabolic Disease Center - San Diego, CA
- Oklahoma Center for Adult Stem Cell Research (OCASCR) - Oklahoma City, OK
- Penn Lab - Cleveland Clinic - Cleveland, OH
- Prantl Laboratory - Center for Adult Stem Cell Research - Regensburg, Germany
- Research & Development Unit - National Heart Centre, Singapore
- RhinoCyte™, Inc. - Louisville, KY
- Scandurro Research Laboratory - New Orleans, LA
- Simari Lab - Mayo Clinic - Rochester, MN
- Skeletal Tissue Engineering Group - Amsterdam
- Skeletal Research Center, Case Western Reserve University - Cleveland, OH
- Stem Cell Biology Laboratory, Pennington Biomedical Research Center - Baton Rouge, LA
- Stem Cell Biology and Cell Therapy Laboratory - Philadelphia, PA
- Stem Cell Research Center - Pittsburgh, PA
- Stem Cell Research Center - Taipei, Taiwan
- Yoder Laboratory - Indianapolis, IN
- Wake Forest Institute of Regenerative Medicine - Winston-Salem, NC